Livingstone Health looks beyond Sinovac boost; to broaden range of services

The multi-disciplinary healthcare group does not want to specialise too narrowly.

Janice Heng

Published Mon, Dec 13, 2021 · 05:50 AM

BEING appointed to lead Sinovac procurement for Singapore's private healthcare institutions might be seen as something of a coup for Livingstone Health Holdings. But chief executive officer Wilson Tay does not wish to overstate the significance of that Covid-19 vaccine's contribution to the healthcare group's prospects.

Seeing it more as "national service", he considers it a non-core part of Livingstone's business - although the healthcare group's "core business" is itself very diverse.

In the half-year ended Sep 30, revenue from the company's family medicine segment rose S$2.2 million "mainly…